array:21 [
  "pii" => "X2013251409005061"
  "issn" => "20132514"
  "doi" => "10.3265/Nefrologia.2009.29.2.4911.en.full"
  "estado" => "S300"
  "fechaPublicacion" => "2009-04-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia (English Version). 2009;29:181"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3494
    "formatos" => array:3 [
      "EPUB" => 216
      "HTML" => 2826
      "PDF" => 452
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699509005064"
      "issn" => "02116995"
      "doi" => "10.3265/Nefrologia.2009.29.2.4911.en.full"
      "estado" => "S300"
      "fechaPublicacion" => "2009-04-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2009;29:181"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 8072
        "formatos" => array:3 [
          "EPUB" => 233
          "HTML" => 7354
          "PDF" => 485
        ]
      ]
      "es" => array:9 [
        "idiomaDefecto" => true
        "titulo" => "ENCEFALOPATÍA POR CEFEPIMA EN PACIENTES CON INSUFICIENCIA RENAL."
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "181"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Cefepime-induced encephalopathy in patients with renal failure"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Carmen Martín Herrera, Macarena Navarro"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Carmen"
                "apellidos" => "Martín Herrera"
              ]
              1 => array:2 [
                "nombre" => "Macarena"
                "apellidos" => "Navarro"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251409005061"
          "doi" => "10.3265/Nefrologia.2009.29.2.4911.en.full"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409005061?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509005064?idApp=UINPBA000064"
      "url" => "/02116995/0000002900000002/v0_201502091411/X0211699509005064/v0_201502091411/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251409005053"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.2009.29.2.4918.en.full"
    "estado" => "S300"
    "fechaPublicacion" => "2009-04-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2009;29:181-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3593
      "formatos" => array:3 [
        "EPUB" => 224
        "HTML" => 2817
        "PDF" => 552
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Ileal intussusception by carcinoid tumour in patients with chronic renal failure"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "181"
          "paginaFinal" => "182"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Intususcepción ileal por tumor carcinoide en paciente con insuficiencia renal crónica"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig1"
          "etiqueta" => "Fig. 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier España"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "21818078_f1_p182.jpg"
              "Alto" => 178
              "Ancho" => 260
              "Tamanyo" => 8666
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ana Isabel Gómez Sotelo, Beatriz Pérez Cabrera, Cristina González Puga, Antonio Palomeque Jimenez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Ana Isabel"
              "apellidos" => "Gómez Sotelo"
            ]
            1 => array:2 [
              "nombre" => "Beatriz"
              "apellidos" => "Pérez Cabrera"
            ]
            2 => array:2 [
              "nombre" => "Cristina"
              "apellidos" => "González Puga"
            ]
            3 => array:2 [
              "nombre" => "Antonio"
              "apellidos" => "Palomeque Jimenez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699509005056"
        "doi" => "10.3265/Nefrologia.2009.29.2.4918.en.full"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509005056?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409005053?idApp=UINPBA000064"
    "url" => "/20132514/0000002900000002/v0_201502091631/X2013251409005053/v0_201502091631/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X201325140900507X"
    "issn" => "20132514"
    "doi" => "10.3265/NEFROLOGIA.2009.29.2.4889.EN.FULL"
    "estado" => "S300"
    "fechaPublicacion" => "2009-04-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2009;29:180-1"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3243
      "formatos" => array:3 [
        "EPUB" => 238
        "HTML" => 2563
        "PDF" => 442
      ]
    ]
    "en" => array:9 [
      "idiomaDefecto" => true
      "titulo" => "CMV disease resistant to Ganciclovir. Should valganciclovir plasma levels be monitored in high risk patients?"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "180"
          "paginaFinal" => "181"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Enfermedad por CMV resistente a ganciclovir ¿Está indicado monitorizar niveles plasmáticos de valganciclovir en pacientes de alto riesgo ?"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "EUGENIA SOLA, ENCARNACION VEGA, CRISTINA GUTIERREZ, VERONICA LOPEZ, MERCEDES CABELLO, DOLORES BURGOS, MIGUEL GONZALEZ MOLINA, JUAN SILES"
          "autores" => array:8 [
            0 => array:2 [
              "nombre" => "EUGENIA"
              "apellidos" => "SOLA"
            ]
            1 => array:2 [
              "nombre" => "ENCARNACION"
              "apellidos" => "VEGA"
            ]
            2 => array:2 [
              "nombre" => "CRISTINA"
              "apellidos" => "GUTIERREZ"
            ]
            3 => array:2 [
              "nombre" => "VERONICA"
              "apellidos" => "LOPEZ"
            ]
            4 => array:2 [
              "nombre" => "MERCEDES"
              "apellidos" => "CABELLO"
            ]
            5 => array:2 [
              "nombre" => "DOLORES"
              "apellidos" => "BURGOS"
            ]
            6 => array:2 [
              "nombre" => "MIGUEL"
              "apellidos" => "GONZALEZ MOLINA"
            ]
            7 => array:2 [
              "nombre" => "JUAN"
              "apellidos" => "SILES"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699509005072"
        "doi" => "10.3265/NEFROLOGIA.2009.29.2.4889.EN.FULL"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509005072?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325140900507X?idApp=UINPBA000064"
    "url" => "/20132514/0000002900000002/v0_201502091631/X201325140900507X/v0_201502091631/en/main.assets"
  ]
  "en" => array:10 [
    "idiomaDefecto" => true
    "titulo" => "Cefepime-induced encephalopathy in patients with renal failure"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "181"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Carmen Martín Herrera, Macarena Navarro"
        "autores" => array:2 [
          0 => array:3 [
            "nombre" => "Carmen"
            "apellidos" => "Martín Herrera"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Macarena"
            "apellidos" => "Navarro"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:3 [
            "entidad" => " Hospitales Universitarios Virgen del Rocío Sevilla, Sevilla, España, "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "ENCEFALOPAT&#205;A POR CEFEPIMA EN PACIENTES CON INSUFICIENCIA RENAL&#46;"
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara">Dear Editor&#44;</p><p class="elsevierStylePara">Cefepime is a fourth-generation cephalosporin that is widely used in hospital settings&#46;<span class="elsevierStyleSup">1 </span>Since its approval&#44; isolated cases of encephalopathy have been reported in patients with both normal<span class="elsevierStyleSup">2</span> and impaired kidney function&#46;<span class="elsevierStyleSup">3&#44;4</span> Nonetheless&#44; the information about the clinical manifestations and the prognosis of this adverse reaction is scarce&#46; Therefore&#44; we believe it is important to report seven cases of cefepime-induced encephalopathy in patients with kidney failure&#46; These cases corresponded to 4 males and 3 females with an average age of 63 years&#46; All of the patients had acute or chronic renal failure when cefepime was prescribed&#46; The average value of creatinine at the beginning of treatment was 3&#46;6mg&#47;dl and the initial dose of cefepime was 2&#46;75g&#47;day&#59; in five patients the dose was adjusted for the degree of kidney function&#46; The average time period between beginning of treatment and symptoms was 5&#46;4 days&#46; The most common clinical manifestations were a decreased level of consciousness &#40;71&#46;4&#37;&#41; and myoclonus &#40;71&#46;4&#37;&#41;&#46; The EEG was pathological in the six cases where it was carried out&#44; demonstrating a nonconvulsive epileptic status in three&#44; slowed global activity with repetitive paroxysm in two&#44; and diffuse affectation with a predominance of triphasic waves in one&#46; The CT scan and the spinal tap were normal in all cases&#46; After diagnosing the encephalopathy&#44; treatment with cefepime was discontinued&#46; Three of the patients received dialysis&#46; Three patients improved &#40;42&#46;9&#37;&#41;&#44; one of whom required haemodialysis&#46; The 4 remaining patients &#40;57&#46;1&#37;&#41; died from the encephalopathy&#46;</p><p class="elsevierStylePara">The use of cefepime in patients with kidney failure&#44; even at adjusted doses&#44; may cause serious encephalopathy&#44; and thus its administration should be avoided or used with close monitoring&#46; The appearance of alterations in the level of consciousness and the myoclonus should alert us to the appearance of a nonconvulsive status that requires an EEG as it is the most useful diagnostic test&#46; Haemodialysis does not seem to modify the clinical outcome&#46;</p>"
    "pdfFichero" => "P-E-S-A217-EN.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "Bibliography"
      "seccion" => array:1 [
        0 => array:1 [
          "bibliografiaReferencia" => array:4 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "1.-Sánchez-Bailén MJ, Navarro Ciruelos N, Rovira García-Marrón R y Anglés Coll. Encefalopatía asociada a la administración de cefepime en uuna paciente con shock séptico e insuficiencia renal. Rev Clin Esp 2004, 204(9): 501-4."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "2.- Maganti R, Jolin D, Rishi D, Biswas A. Nonconvulsive statuus epilecticus due to cefepime in a patient with normal renal function. Epilepsy&Behavior 2006, 8: 312-314."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "3.-Chatelier D, Jourdan M, Mangalaboyi J. and cols. Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med 2002, 28: 214-217. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11907668" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "4.-Barbey F, Bugnon D, Wauters JP. Neurotoxicity of Cefepime in Uremic Patients. Ann Intern Med, 2001, 135: 1011. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11730416" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002900000002/v0_201502091631/X2013251409005061/v0_201502091631/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35436"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letters to the Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002900000002/v0_201502091631/X2013251409005061/v0_201502091631/en/P-E-S-A217-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409005061?idApp=UINPBA000064"
]
Share
Journal Information
Vol. 29. Issue. 2.April 2009
Pages 95-184
Full text access
Cefepime-induced encephalopathy in patients with renal failure
ENCEFALOPATÍA POR CEFEPIMA EN PACIENTES CON INSUFICIENCIA RENAL.
Visits
8512
Carmen Martín Herreraa, Macarena Navarroa
a Hospitales Universitarios Virgen del Rocío Sevilla, Sevilla, España,
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

Dear Editor,

Cefepime is a fourth-generation cephalosporin that is widely used in hospital settings.1 Since its approval, isolated cases of encephalopathy have been reported in patients with both normal2 and impaired kidney function.3,4 Nonetheless, the information about the clinical manifestations and the prognosis of this adverse reaction is scarce. Therefore, we believe it is important to report seven cases of cefepime-induced encephalopathy in patients with kidney failure. These cases corresponded to 4 males and 3 females with an average age of 63 years. All of the patients had acute or chronic renal failure when cefepime was prescribed. The average value of creatinine at the beginning of treatment was 3.6mg/dl and the initial dose of cefepime was 2.75g/day; in five patients the dose was adjusted for the degree of kidney function. The average time period between beginning of treatment and symptoms was 5.4 days. The most common clinical manifestations were a decreased level of consciousness (71.4%) and myoclonus (71.4%). The EEG was pathological in the six cases where it was carried out, demonstrating a nonconvulsive epileptic status in three, slowed global activity with repetitive paroxysm in two, and diffuse affectation with a predominance of triphasic waves in one. The CT scan and the spinal tap were normal in all cases. After diagnosing the encephalopathy, treatment with cefepime was discontinued. Three of the patients received dialysis. Three patients improved (42.9%), one of whom required haemodialysis. The 4 remaining patients (57.1%) died from the encephalopathy.

The use of cefepime in patients with kidney failure, even at adjusted doses, may cause serious encephalopathy, and thus its administration should be avoided or used with close monitoring. The appearance of alterations in the level of consciousness and the myoclonus should alert us to the appearance of a nonconvulsive status that requires an EEG as it is the most useful diagnostic test. Haemodialysis does not seem to modify the clinical outcome.

Bibliography
[1]
1.-Sánchez-Bailén MJ, Navarro Ciruelos N, Rovira García-Marrón R y Anglés Coll. Encefalopatía asociada a la administración de cefepime en uuna paciente con shock séptico e insuficiencia renal. Rev Clin Esp 2004, 204(9): 501-4.
[2]
2.- Maganti R, Jolin D, Rishi D, Biswas A. Nonconvulsive statuus epilecticus due to cefepime in a patient with normal renal function. Epilepsy&Behavior 2006, 8: 312-314.
[3]
3.-Chatelier D, Jourdan M, Mangalaboyi J. and cols. Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med 2002, 28: 214-217. [Pubmed]
[4]
4.-Barbey F, Bugnon D, Wauters JP. Neurotoxicity of Cefepime in Uremic Patients. Ann Intern Med, 2001, 135: 1011. [Pubmed]
Download PDF
Idiomas
Nefrología (English Edition)
Article options
Tools